Science ❯ Life Sciences ❯ Pharmacology ❯ Drug Development
Researchers at Hiroshima University will test purified TM3-4 peptides in animal models following cell studies that showed the amino acid sequences disrupt VIPR2 pairing essential for tumor progression.
